01—Abstract
Summary
Summary of the 10-K filed February 10, 2023. Cited figures are marked; the original filing is the authoritative source.
Philip Morris International Inc. (PM) reported its 2022 fiscal year results, marked by significant strategic shifts and a notable acquisition.
The company's transformation towards a smoke-free future remains a core focus, evidenced by continued investment in reduced-risk products (RRPs). A pivotal event was the acquisition of Swedish Match AB in November 2022, bolstering PMI's position in the oral nicotine market with the ZYN brand and complementing its IQOS heat-not-burn offering. This move is expected to accelerate the company's smoke-free ambitions.
Financially, PMI reported net revenues of $31.8 billiona, a slight increase from the previous year, driven by growth in smoke-free products and favorable pricing, although impacted by currency headwinds and charges related to the war in Ukraine. Diluted EPS saw a minor decrease.
The company also reached an agreement with Altria Group, Inc. to reacquire U.S. commercialization rights for IQOS, effective May 2024, signaling a strategic move to directly control its key smoke-free product in a major market. Despite geopolitical challenges and ongoing regulatory scrutiny, PMI is actively managing its portfolio and investing in future growth drivers.
02—Key points
Key Highlights
- Acquisition of Swedish Match AB completed in November 2022, significantly expanding PMI's smoke-free product portfolio, particularly in the oral nicotine category (ZYN).
- Agreement reached with Altria to reacquire U.S. commercialization rights for IQOS, effective May 1, 2024, allowing PMI direct control in a key market.
- Net revenues reached $31.8 billion, a 1.1% increase year-over-year, primarily driven by growth in smoke-free products and favorable pricing, partially offset by currency fluctuations and the impact of the war in Ukraine.
- Diluted EPS slightly decreased to $5.81 from $5.83 in the prior year, impacted by charges related to the war in Ukraine and acquisition-related costs.
- Total shipment volume increased by 1.6%, with heated tobacco units (HTUs) showing a significant 14.9% increase, indicating continued consumer adoption of smoke-free alternatives.
- PMI is making substantial investments in its smoke-free product manufacturing capacity, including for IQOS ILUMA and Swedish Match's portfolio, with expected capital expenditures of $1.3 billion in 2023.
- The company continues to prioritize sustainability and its transformation to a smoke-free future, investing heavily in R&D for reduced-risk products.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2022, Philip Morris International Inc. kept $0.28.
- Revenue$31.76B100.0%
- Cost of revenue−$11.40B35.9%
- Gross profit$20.36B64.1%
- Operating costs−$8.11B25.5%
- Operating income$12.25B38.6%
- Interest, other & tax−$3.20B10.1%
- Net income$9.05B28.5%
Where FY2022 revenue went
$31.76B- Cost of revenue: $11.40B, 36% of revenue
- Net income: $9.05B, 28% of revenue
- Other operating costs: $7.47B, 24% of revenue
- R&D: $642.0M, 2.0% of revenue
- Interest, other & tax: $3.20B, 10% of revenue
Kept 28% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2022filed February 10, 2023Financial Statements
FY2022 against FY2021
| Line item | FY2022FY2021 | Change |
|---|---|---|
| Revenue | $31.76B$31.41B | +1.1% |
| Cost of Revenue | $11.40B$10.03B | +13.7% |
| Gross Profit | $20.36B$21.38B | −4.7% |
| R&D Expenses | $642.00M$617.00M | +4.1% |
| Operating Income | $12.25B$12.97B | −5.6% |
| Interest Expense | $768.00M$737.00M | +4.2% |
| Net Income | $9.05B$9.11B | −0.7% |
| EPS (Basic) | $5.82$5.83 | −0.2% |
| EPS (Diluted) | $5.81$5.83 | −0.3% |
| Shares Outstanding (Basic) | 1.55B1.56B | −0.5% |
| Shares Outstanding (Diluted) | 1.55B1.56B | −0.4% |
05—Questions
Frequently Asked Questions
What was the impact of the Swedish Match acquisition on PMI's financial performance?
The acquisition of Swedish Match, completed in November 2022, contributed $316 million in net revenues and a net loss of $22 million to PMI's results for the period from the acquisition date to December 31, 2022. The acquisition also resulted in the recording of $13.3 billion in goodwill and $4.5 billion in intangible assets, reflecting the strategic value of Swedish Match's oral nicotine portfolio.
How is PMI addressing the war in Ukraine and its impact on operations?
PMI has taken steps to ensure employee safety in Ukraine and Russia, suspending commercial and manufacturing operations in Ukraine and scaling down operations in Russia. The company recorded pre-tax charges of $151 million in 2022 related to the war, impacting its Eastern Europe segment. While these developments have had a material adverse impact, PMI continues to support its employees in the region and is assessing the evolving situation.
What is the significance of PMI reacquiring U.S. IQOS rights from Altria?
PMI's agreement with Altria to reacquire the U.S. commercialization rights for IQOS, effective May 1, 2024, is a significant strategic move. It allows PMI to directly manage and market its flagship smoke-free product in the large U.S. market, aligning with its long-term transformation goals and capturing the full value of its investment in the product.
How is PMI diversifying beyond traditional tobacco products?
PMI is actively diversifying its portfolio through acquisitions and investments in the wellness and healthcare sectors, including the acquisitions of Vectura Group plc and Fertin Pharma A/S. These moves aim to build capabilities in life sciences and expand into new growth areas outside of nicotine and tobacco.
06—Continue